Shoulder Innovations, Inc. (NYSE: SI) Stock Competitors & Peer Comparison
See SI's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SI and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SI | $18.90 | +0.59% | 392M | -10.92 | -$1.73 | N/A |
| ALC | $64.75 | -1.05% | 31.6B | 20.36 | $3.18 | +0.55% |
| STE | $210.01 | -0.30% | 20.5B | 20.17 | $10.42 | +1.23% |
| MLAB | $129.94 | -0.79% | 727.1M | 13.11 | $9.91 | +0.49% |
| QDEL | $10.54 | -0.52% | 718.7M | 7.87 | $1.34 | N/A |
| BWAY | $13.20 | -2.08% | 517.7M | 33.53 | $0.39 | N/A |
| MASS | $12.34 | +4.14% | 506.3M | -20.57 | -$0.60 | N/A |
| MOBI | $9.45 | +4.77% | 314.2M | -4.90 | -$1.93 | N/A |
| LAB | $0.74 | +3.83% | 289.9M | -10.58 | -$0.07 | N/A |
| ANIK | $19.66 | -1.43% | 263.1M | 40.12 | $0.49 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
SI vs ALC Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, ALC has a market cap of 31.6B. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while ALC trades at $64.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas ALC's P/E ratio is 20.36. In terms of profitability, SI's ROE is -0.26%, compared to ALC's ROE of +0.03%. Regarding short-term risk, SI is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for SI.Check ALC's competition here
STERIS plc (NYSE: STE)
SI vs STE Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, STE has a market cap of 20.5B. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while STE trades at $210.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas STE's P/E ratio is 20.17. In terms of profitability, SI's ROE is -0.26%, compared to STE's ROE of +0.11%. Regarding short-term risk, SI is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for SI.Check STE's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
SI vs MLAB Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, MLAB has a market cap of 727.1M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while MLAB trades at $129.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas MLAB's P/E ratio is 13.11. In terms of profitability, SI's ROE is -0.26%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, SI is more volatile compared to MLAB. This indicates higher risk in terms of short-term price fluctuations for SI.Check MLAB's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
SI vs QDEL Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, QDEL has a market cap of 718.7M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while QDEL trades at $10.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas QDEL's P/E ratio is 7.87. In terms of profitability, SI's ROE is -0.26%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, SI is more volatile compared to QDEL. This indicates higher risk in terms of short-term price fluctuations for SI.Check QDEL's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
SI vs BWAY Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, BWAY has a market cap of 517.7M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while BWAY trades at $13.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas BWAY's P/E ratio is 33.53. In terms of profitability, SI's ROE is -0.26%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, SI is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for SI.Check BWAY's competition here
908 Devices Inc. (NASDAQ: MASS)
SI vs MASS Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, MASS has a market cap of 506.3M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while MASS trades at $12.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas MASS's P/E ratio is -20.57. In terms of profitability, SI's ROE is -0.26%, compared to MASS's ROE of -0.25%. Regarding short-term risk, SI is more volatile compared to MASS. This indicates higher risk in terms of short-term price fluctuations for SI.Check MASS's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
SI vs MOBI Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, MOBI has a market cap of 314.2M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while MOBI trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas MOBI's P/E ratio is -4.90. In terms of profitability, SI's ROE is -0.26%, compared to MOBI's ROE of +0.80%. Regarding short-term risk, SI is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for SI.Check MOBI's competition here
Standard BioTools Inc. (NASDAQ: LAB)
SI vs LAB Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, LAB has a market cap of 289.9M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while LAB trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas LAB's P/E ratio is -10.58. In terms of profitability, SI's ROE is -0.26%, compared to LAB's ROE of -0.18%. Regarding short-term risk, SI is more volatile compared to LAB. This indicates higher risk in terms of short-term price fluctuations for SI.Check LAB's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
SI vs ANIK Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, ANIK has a market cap of 263.1M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while ANIK trades at $19.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas ANIK's P/E ratio is 40.12. In terms of profitability, SI's ROE is -0.26%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, SI is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for SI.Check ANIK's competition here
Edap Tms S.a. (NASDAQ: EDAP)
SI vs EDAP Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas EDAP's P/E ratio is -5.80. In terms of profitability, SI's ROE is -0.26%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, SI is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for SI.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
SI vs NYXH Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, NYXH has a market cap of 138.1M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while NYXH trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas NYXH's P/E ratio is -0.55. In terms of profitability, SI's ROE is -0.26%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, SI is more volatile compared to NYXH. This indicates higher risk in terms of short-term price fluctuations for SI.Check NYXH's competition here
Trinity Biotech plc (NASDAQ: TRIB)
SI vs TRIB Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, TRIB has a market cap of 130.2M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while TRIB trades at $6.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas TRIB's P/E ratio is -0.11. In terms of profitability, SI's ROE is -0.26%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, SI is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for SI.Check TRIB's competition here
Apyx Medical Corporation (NASDAQ: APYX)
SI vs APYX Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, APYX has a market cap of 105.5M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while APYX trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas APYX's P/E ratio is -12.52. In terms of profitability, SI's ROE is -0.26%, compared to APYX's ROE of -0.79%. Regarding short-term risk, SI is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for SI.Check APYX's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
SI vs SKIN Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, SKIN has a market cap of 81.6M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while SKIN trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas SKIN's P/E ratio is -2.86. In terms of profitability, SI's ROE is -0.26%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, SI is more volatile compared to SKIN. This indicates higher risk in terms of short-term price fluctuations for SI.Check SKIN's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
SI vs MDAI Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, MDAI has a market cap of 52.8M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while MDAI trades at $1.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas MDAI's P/E ratio is -3.69. In terms of profitability, SI's ROE is -0.26%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, SI is more volatile compared to MDAI. This indicates higher risk in terms of short-term price fluctuations for SI.Check MDAI's competition here
DarioHealth Corp. (NASDAQ: DRIO)
SI vs DRIO Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, DRIO has a market cap of 51.5M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while DRIO trades at $6.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas DRIO's P/E ratio is -1.20. In terms of profitability, SI's ROE is -0.26%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, SI is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for SI.Check DRIO's competition here
HeartBeam, Inc. (NASDAQ: BEAT)
SI vs BEAT Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, BEAT has a market cap of 20.3M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while BEAT trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas BEAT's P/E ratio is -0.72. In terms of profitability, SI's ROE is -0.26%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, SI is more volatile compared to BEAT. This indicates higher risk in terms of short-term price fluctuations for SI.Check BEAT's competition here
Spectral AI, Inc. (NASDAQ: MDAIW)
SI vs MDAIW Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, MDAIW has a market cap of 15.1M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while MDAIW trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas MDAIW's P/E ratio is -1.34. In terms of profitability, SI's ROE is -0.26%, compared to MDAIW's ROE of N/A. Regarding short-term risk, SI is less volatile compared to MDAIW. This indicates lower risk in terms of short-term price fluctuations for SI.Check MDAIW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
SI vs BEATW Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, BEATW has a market cap of 4.3M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while BEATW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas BEATW's P/E ratio is -0.01. In terms of profitability, SI's ROE is -0.26%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, SI is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for SI.Check BEATW's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
SI vs WOK Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, WOK has a market cap of 4.3M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while WOK trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas WOK's P/E ratio is N/A. In terms of profitability, SI's ROE is -0.26%, compared to WOK's ROE of -0.19%. Regarding short-term risk, SI is more volatile compared to WOK. This indicates higher risk in terms of short-term price fluctuations for SI.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
SI vs QTEXW Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, SI's ROE is -0.26%, compared to QTEXW's ROE of N/A. Regarding short-term risk, SI is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for SI.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
SI vs ITOC Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, ITOC has a market cap of 2.6M. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while ITOC trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas ITOC's P/E ratio is -0.90. In terms of profitability, SI's ROE is -0.26%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, SI is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for SI.Check ITOC's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
SI vs FEED Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, FEED has a market cap of 798K. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while FEED trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas FEED's P/E ratio is -0.15. In terms of profitability, SI's ROE is -0.26%, compared to FEED's ROE of -0.60%. Regarding short-term risk, SI is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for SI.Check FEED's competition here
Tivic Health Systems, Inc. (NASDAQ: TIVC)
SI vs TIVC Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 392M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, SI is priced at $18.90 on the NYSE, while TIVC trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.92, whereas TIVC's P/E ratio is -0.04. In terms of profitability, SI's ROE is -0.26%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, SI is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for SI.Check TIVC's competition here